Naslov
Attenuating emerging contaminants - prospects and new approaches

Autori
Vrček, Valerije

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, neobjavljeni rad, znanstveni

Skup
BoDEREC-CE Final Conference

Mjesto i datum
Prag, Češka Republika, 02.03.2022

Vrsta sudjelovanja
Predavanje

Vrsta recenzije
Nije recenziran

Ključne riječi
lijekovi, okoliš
(pharmaceuticals, environment)

Sažetak
PPCPs selected (Table 1) for attenuation study are derived from the lists included in deliverables D.T1.3.1 (National review papers on emerging contaminants appearing in the water environment) and D.T3.3.3 (First set-up for modeling transport of emerging contaminants in hydrological systems). In these deliverables, all PPCPs were introduced by the authors (i.e. the members of the bo-DEREC- CE project), responsible for different pilot actions areas. In addition, PPCP with the highest concentration (in ng/L) measured in at each respective pilot action areas have also been included in Table 1 (if not present earlier in deliverables D.T1.3.1 and D.T3.3.3). This collection of PPCPs is broad and representative, as it containing contains ubiquitous compounds (carbamazepine, diclofenac), popular over-the- counter (OTC) drugs (ibuprofen), different therapeutic classes, such as antibiotics (sulfamethoxazole), hormones (progesterone, testosterone), antidiabetics (metformin), antihypertensives (valsartan), or anticonvulsants (lamotrigine, gabapentin), but also PPCP metabolites (oxypurinol, 4-formylaminoantipyrine) and personal care substances (DEET, benzotriazole). In addition, some of PPCPs listed in Table 1 (diclofenac, sulfamethoxazole) have been filed in the Watch List under the Water Framework Directive.

Izvorni jezik
Engleski

Znanstvena područja
Kemija, Farmacija

POVEZANOST RADA